Diego A Díaz-Dinamarca (Diego A Diaz-Dinamarca)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Plasmodium Falciparum

Regulatory T Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Diego A Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A Muena, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Daniel F Escobar, Michal Díaz-Samirin, Natalia T Santis-Alay, Cecilia Canales, Janepsy Díaz, Heriberto E García-Escorza, Alba Grifoni, Alessandro Sette, Nicole D Tischler, Abel E Vásquez
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac. Vaccines 12 (8) (2024)
Diego A Díaz-Dinamarca, Michelle L Salazar, Byron N Castillo, Augusto Manubens, Abel E Vásquez, Fabián Salazar, María Inés Becker
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. Pharmaceutics 14 (8) (2022)
Diego A Díaz-Dinamarca, Carlos Hernandez, Daniel F Escobar, Daniel A Soto, Guillermo A Muñoz, Jesús F Badilla, Ricardo A Manzo, Flavio Carrión, Alexis M Kalergis, Abel E Vásquez
Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model. Vaccines 8 (2) (2020)
Diego A Díaz-Dinamarca, Ricardo A Manzo, Daniel A Soto, María José Avendaño-Valenzuela, Diego N Bastias, Paulina I Soto, Daniel F Escobar, Valeria Vasquez-Saez, Flavio Carrión, Magdalena S Pizarro-Ortega, Christian A M Wilson, Julio Berrios, Alexis M Kalergis, Abel E Vásquez
Surface Immunogenic Protein of Streptococcus Group B is an Agonist of Toll-Like Receptors 2 and 4 and a Potential Immune Adjuvant. Vaccines 8 (1) (2020)